Today: 7 February 2026
Subscribe
Browse Category

NASDAQ:SNOW News 30 November 2025 - 7 February 2026

Snowflake stock rebounds 7% after AI-software jitters; SNOW earnings next big test

Snowflake stock rebounds 7% after AI-software jitters; SNOW earnings next big test

Snowflake shares jumped 7.5% to $168.43 on Friday, recovering part of a three-day slide that saw the stock drop from $190.68 to $156.71. The rebound follows the company’s move to offer Anthropic’s Claude Opus 4.6 on its Cortex AI platform. Investors are watching for Snowflake’s quarterly results on Feb. 25 amid ongoing volatility in software stocks.
7 February 2026
····
Snowflake stock skids as AI fears hit software; SNOW eyes Feb. 25 earnings

Snowflake stock skids as AI fears hit software; SNOW eyes Feb. 25 earnings

Snowflake Inc shares fell 7.5% to $160.24 by early afternoon Wednesday amid investor concerns over AI’s impact on software business models. The company announced a $200 million multi-year deal with OpenAI and launched new AI tools, including Cortex Code and Semantic View Autopilot. Snowflake’s fiscal 2026 results are due Feb. 25 after market close.
4 February 2026
···
Why Snowflake stock slid 9%: AI disruption jitters swamp an OpenAI tie-up and a Postgres push

Why Snowflake stock slid 9%: AI disruption jitters swamp an OpenAI tie-up and a Postgres push

Snowflake shares fell 9.1% Tuesday to $173.24, following a $200 million OpenAI partnership and new product updates. The drop came as investors sold off software and cloud stocks after Anthropic launched new AI tools, raising concerns about pricing power and competition. Snowflake highlighted new features and integrations but faces pressure ahead of its February 25 earnings report.
4 February 2026
S&P 500, Nasdaq slip as software rout deepens; Palantir jumps and Walmart hits $1 trillion

S&P 500, Nasdaq slip as software rout deepens; Palantir jumps and Walmart hits $1 trillion

The S&P 500 fell 0.45% and the Nasdaq dropped 1.02% Tuesday as software stocks slid, while the Dow edged up 0.08%. Palantir shares rose after reporting U.S. government revenue up 66% in Q4. Walmart’s market value topped $1 trillion for the first time. The U.S. Labor Department delayed key jobs data due to a partial government shutdown.
3 February 2026
·········
Snowflake stock slides nearly 8% in software rout; traders brace for next catalyst

Snowflake stock slides nearly 8% in software rout; traders brace for next catalyst

Snowflake shares fell 7.7% to $199.37 Thursday, tracking a sharp selloff in software stocks amid fears that AI could disrupt subscription-based models. The S&P 500 Software and Services Index dropped 8.7% to a nine-month low. Snowflake’s recent launch of an energy-focused data package failed to offset sector-wide concerns. No new financial results were released by the company this week.
30 January 2026
··
10 Best Stocks to Buy Now for the Week of December 1–5, 2025: AI, Cybersecurity and Retail in Focus

10 Best Stocks to Buy Now for the Week of December 1–5, 2025: AI, Cybersecurity and Retail in Focus

As the first trading week of December 2025 gets underway, U.S. stocks are hovering near record highs, powered by hopes that the Federal Reserve will cut interest rates at its December 9–10 meeting. Futures markets are pricing in roughly an 80–85% chance of another 25 basis point cut, according to CME FedWatch data cited by JPMorgan, UBS and other major banks. Reuters+2United States of America+2 At the same time, investors are laser‑focused on whether the “AI trade” can keep delivering profits. A Reuters “Wall St Week Ahead” piece notes that the S&P 500 is up about 16% so far this
30 November 2025
············

Stock Market Today

AstraZeneca stock price: What could move AZN next week as earnings loom

AstraZeneca stock price: What could move AZN next week as earnings loom

7 February 2026
AstraZeneca shares rose Friday, closing at $193.03 in New York, up 3.1%, and 14,104p in London, up 0.9%. The company reports full-year and Q4 2025 results Tuesday, with investors focused on 2026 guidance. The FDA this week issued a complete response letter for a subcutaneous Saphnelo filing, while granting Priority Review to Datroway for breast cancer. AstraZeneca recently shifted its primary U.S. listing to the NYSE.
Toyota stock price rises on CEO shake-up and higher profit outlook as buyout deadline nears

Toyota stock price rises on CEO shake-up and higher profit outlook as buyout deadline nears

7 February 2026
Toyota shares rose 2% to 3,780 yen Friday after the company raised its full-year profit forecast and announced CFO Kenta Kon will replace CEO Koji Sato on April 1. Third-quarter net revenues climbed 6.8% to 38.087 trillion yen, but North America posted a 5.6 billion yen operating loss. Toyota’s U.S. ADRs closed up 2.9%. The tender offer for Toyota Industries shares closes Feb. 12.
Go toTop